Coegin Pharma AB: BioStock: Coegin Pharma takes advantage of decentralised clinical trials

Read the full interview with CEO of Studie&Me, John Zibert and CEO of Coegin Pharma, Tore Duvold at biostock.se:

https://www.biostock.se/en/coegin-pharma-takes-advantage-of-decentralised-clinical-trials/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/